[Hong Kong, May 24, 2023] Great Bay Bio (hereinafter referred to as “GBB”) was successfully admitted into the Elite Programme. The Elite Programme is a highly selective incubation and acceleration programme of Hong Kong Science & Technology Park (hereinafter referred to as “HKSTP”), providing up to HK$21.5M support to innovation and technology enterprises with strong growth potentials to further expand its business outside Hong Kong and eventually become a unicorn. The programme requires that the candidate companies have unique technology with early success in business, a scalable and ready-to-go international business model and completed series A funding.

"We are very proud to be the first biotech company to enter the programme since its revamp in 2022. At the same time, I am extremely excited to see the amazing effort HKSTP has put in building Hong Kong’s start-up ecosystem. With the trust and support from HKSTP, GBB will continue to strive to meet our upcoming milestones, including but not limited to optimizing our existing AI platforms and completing another fund raising. Ultimately, we aim to build the world’s first end-to-end AI + Bioprocessing platform, solving major R&D pain points in many important biotechnology verticals, including biopharmaceuticals, IVD, synthetic biology and more."